V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20222223 | 20084416 | 1.72 | 78.5 | Palliative (P) | 2018-09-17 | 2018-09-21 | Cetuximab 14 day | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101633686 |
| 20222225 | 20084417 | 1.6 | 60.2 | Curative (C) | 2019-12-13 | 2019-12-13 | Enzalutamide | N | N | MITOMYCIN INTRAVESICULAR | 100890997 |
| 20222227 | 20084418 | 1.73 | null | null | 2017-11-23 | 2017-12-21 | Enzalutamide | 02 | null | CARBOPLATIN + GEMCITABINE | 101864374 |
| 20222231 | 20084419 | 1.67 | 68.8 | Curative (C) | 2017-06-24 | 2017-06-24 | Enzalutamide | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101504788 |
| 20222234 | 20084420 | null | 69 | Neo-adjuvant (N) | null | 2019-07-17 | Enzalutamide | 02 | Y | OCTREOTIDE | 101051767 |
| 20222244 | 20084421 | 1.6 | 87.2 | Neo-adjuvant (N) | 2016-07-17 | 2016-07-22 | Enzalutamide | 02 | N | ECF | 101587234 |
| 20222245 | 20084422 | 1.71 | 75 | Palliative (P) | 2018-09-28 | 2018-10-11 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101282161 |
| 20222248 | 20084423 | 1.73 | 71.6 | Neo-adjuvant (N) | null | 2017-06-06 | Enzalutamide | 02 | N | CISPLATIN | 100143135 |
| 20222254 | 20084424 | 1.59 | 51.6 | Palliative (P) | 2016-04-28 | 2016-05-03 | Capecitabine + Cisplatin + RT | 02 | N | CARBOPLATIN | 100639867 |
| 20222255 | 20084425 | 1.62 | 67.4 | Palliative (P) | 2017-01-11 | 2017-01-21 | Enzalutamide | N | N | OCTREOTIDE | 101413708 |
| 20222266 | 20084426 | 1.57 | 48.9 | Neo-adjuvant (N) | 2018-02-17 | 2018-02-17 | Enzalutamide | 02 | N | TRASTUZUMAB | 101300910 |
| 20222275 | 20084427 | 1.71 | 66.9 | null | 2019-05-20 | 2019-05-27 | Enzalutamide | N | null | TRASTUZUMAB | 101611951 |
| 20222276 | 20084428 | 1.72 | 59.8 | 03 | 2018-07-20 | 2018-07-20 | Enzalutamide | 02 | N | OCTREOTIDE | 101830647 |
| 20222281 | 20084429 | 1.7 | null | Adjuvant (A) | 2018-05-26 | 2018-05-26 | Enzalutamide | 02 | null | CARBOPLATIN + GEMCITABINE | 101821058 |
| 20222283 | 20084430 | 1.6 | 43.5 | Adjuvant (A) | null | 2018-10-17 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101667526 |
| 20222286 | 20084431 | 1.8 | null | Palliative (P) | 2019-09-02 | 2019-09-07 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100566800 |
| 20222291 | 20084432 | null | 67.4 | Palliative (P) | 2017-09-08 | 2017-09-08 | Enzalutamide | 02 | N | OCTREOTIDE | 100577090 |
| 20222298 | 20084433 | 1.6 | 73.4 | Curative (C) | 2017-07-16 | 2017-07-24 | TRASTUZUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100692985 |
| 20222300 | 20084434 | 0 | 108.4 | Palliative (P) | 2016-12-04 | 2016-12-04 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101322529 |
| 20222302 | 20084435 | 1.78 | 71 | Palliative (P) | 2019-02-15 | 2019-02-23 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101492056 |
| 20222306 | 20084436 | 1.55 | 92.4 | Palliative (P) | 2017-07-22 | 2017-07-22 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + CISPLATIN + RT | 101569150 |
| 20222307 | 20084437 | 1.57 | null | null | 2018-12-25 | 2018-12-25 | Enzalutamide | 02 | null | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100500353 |
| 20222310 | 20084438 | 1.67 | 83 | Curative (C) | 2018-08-12 | 2018-08-17 | Carboplatin AUC 2 - 5 | 02 | N | ECF | 101482842 |
| 20222312 | 20084439 | 0 | 0 | Palliative (P) | 2019-02-28 | 2019-02-28 | Enzalutamide | null | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100957315 |
| 20222314 | 20084440 | 0 | 0 | Palliative (P) | 2019-11-10 | 2019-11-19 | Capecitabine + Cisplatin + RT | 02 | N | TRASTUZUMAB | 101610653 |
| 20222318 | 20084441 | 1.71 | 60.7 | Neo-adjuvant (N) | 2019-04-17 | 2019-04-17 | Enzalutamide | 2 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101635553 |
| 20222319 | 20084442 | 1.78 | 84.85 | Palliative (P) | 2018-10-05 | 2018-10-06 | Enzalutamide | 2 | N | TRASTUZUMAB | 101357875 |
| 20222321 | 20084443 | 1.59 | 57.7 | Neo-adjuvant (N) | 2018-03-28 | 2018-03-28 | Enzalutamide | 02 | N | OXALIPLATIN + RALTITREXED | 100604467 |
| 20222322 | 20084444 | 1.75 | 85.2 | Palliative (P) | 2016-11-09 | 2016-11-09 | Enzalutamide | 02 | N | TRASTUZUMAB | 101518462 |
| 20222324 | 20084445 | 1.55 | 82.1 | null | 2016-06-18 | 2016-06-18 | Enzalutamide | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 100915671 |
| 20222326 | 20084446 | 1.55 | 79.75 | Adjuvant (A) | 2016-09-29 | 2016-10-08 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 101263238 |
| 20222329 | 20084447 | 1.7 | 79.9 | null | 2018-04-26 | 2018-04-27 | Enzalutamide | 02 | null | ENZALUTAMIDE | 100678597 |
| 20222331 | 20084448 | 1.59 | 81.5 | Palliative (P) | 2018-05-18 | 2018-05-18 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101370002 |
| 20222336 | 20084449 | 0 | 0 | Palliative (P) | 2016-05-08 | 2016-05-12 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101123966 |
| 20222343 | 20084450 | 1.8 | 66.2 | Curative (C) | 2016-07-25 | 2016-08-06 | Enzalutamide | 02 | N | CISPLATIN | 101557631 |
| 20222352 | 20084451 | 0 | 0 | Palliative (P) | 2016-09-14 | 2016-09-21 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100193010 |
| 20222353 | 20084452 | null | 66 | null | null | 2018-12-24 | Mitomycin Intravesical | 02 | null | MITOMYCIN INTRAVESICULAR | 100649789 |
| 20222362 | 20084453 | 1.68 | 115.5 | Palliative (P) | 2017-03-19 | 2017-03-19 | Enzalutamide | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100910131 |
| 20222368 | 20084454 | 1.86 | 60.3 | Neo-adjuvant (N) | 2016-09-04 | 2016-09-05 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100319905 |
| 20222379 | 20084455 | 1.67 | 66 | Palliative (P) | 2021-08-07 | 2021-09-04 | Enzalutamide | 02 | N | SCALOP-2 TRIAL | 101116397 |
| 20222383 | 20084456 | 1.55 | 54.2 | Neo-adjuvant (N) | 2018-06-14 | 2018-06-28 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101819451 |
| 20222384 | 20084457 | 1.67 | 71.2 | 03 | 2017-11-17 | 2017-11-18 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101733367 |
| 20222392 | 20084458 | 1.53 | 83.4 | Curative (C) | 2019-11-22 | 2019-11-27 | LUTETIUM-177 | 02 | null | LUTETIUM-177 | 101034881 |
| 20222401 | 20084459 | 1.6 | 61.7 | null | 2019-01-13 | 2019-01-13 | Capecitabine + Cisplatin + RT | 02 | null | ECF | 100751973 |
| 20222406 | 20084460 | 0 | 68.2 | Palliative (P) | 2018-12-23 | 2019-01-07 | CARBOPLATIN + PACLITAXEL + RT | N | N | CARBOPLATIN + PACLITAXEL + RT | 100921967 |
| 20222407 | 20084461 | 1.75 | 72.25 | Neo-adjuvant (N) | 2019-02-17 | 2019-03-04 | Capecitabine + Cisplatin + RT | N | Y | CAPECITABINE + CISPLATIN + RT | 100468363 |
| 20222408 | 20084462 | 1.78 | null | Neo-adjuvant (N) | 2017-01-19 | 2017-01-19 | Enzalutamide | N | null | ATEZOLIZUMAB + BEVACIZUMAB | 101376100 |
| 20222410 | 20084463 | 1.7 | 56 | Neo-adjuvant (N) | 2019-03-20 | 2019-03-20 | Capecitabine + Cisplatin + RT | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101182989 |
| 20222417 | 20084465 | 1.75 | 80 | null | 2018-01-16 | 2018-01-16 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100974787 |
| 20222423 | 20084466 | null | 84 | Palliative (P) | 2018-10-20 | 2018-10-27 | Enzalutamide | 02 | null | ECF | 100188632 |